Precigen provides latest clinical developments at virtual r&d update event

Germantown, md., dec. 15, 2020 /prnewswire/ -- precigen, inc. (nasdaq: pgen), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today held an r&d virtual event to provide an update on the latest progress for...
PGEN Ratings Summary
PGEN Quant Ranking